Core Laboratories N.V. Stock Price and Value Analysis

Should you buy Core Laboratories N.V. stock? (NYSE:CLB). Let's see how it does in our automated value investing analysis system.

Key Facts

  • Ticker: CLB (NYSE)
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield:

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Core Laboratories N.V. to reach your target.

Target type
AdvantagesDisadvantages
  • This stock is available at a great discount!
  • This company is making money at a decent rate.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This company has a low dividend yield.

Inside the CLB Numbers

CLB Price
(Core Laboratories N.V. stock price per share)
$18.90
[?] CLB Fair Price
(based on intrinsic value)
$38.61
[?] CLB Safety Price (based on a variable margin of safety) $23.17
[?] PE Ratio versus Sector 328% higher than other Unknown stocks
[?] PE Ratio versus Industry 62% higher than other Unknown stocks
[?] Cash Yield 25.40%
[?] Free Cash Flow Jitter 47%
[?] Dividend Yield 0% (tax impact)
Shares Shorted 4,305,627

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,305,627 shares shorted. With 46,708,773 shares available for purchase and an average trading volume over the past 10 trading days of 341,580, it would take at least 12.605 days for all of the short holders to cover their shorts.

What does this mean to you? At this volume, it'll take more than two trading weeks for shorts to cover. This may indicate a short squeeze play would work! If this stock has good fundamentals and it'll take a while for the short holders to cover, buying now could net you bigger short-term technical gains if and as the price rises.

Continue Learning: Value Investing Guides

Is Core Laboratories N.V. Stock on Sale?

We believe that Core Laboratories N.V. may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Even better, Core Laboratories N.V. looks like a stock on sale. Based on our analysis—if the company keeps making money the way it has been—you may be looking at a bargain. Keep this stock in mind as you put together your portfolio! See Before You Buy for your next steps (and read our disclaimer about investing risk).

Advertisement supports free stock analysis content.

Should You Buy CLB Stock?

Does Core Laboratories N.V. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: CLB

This example shows how we apply the Trendshare checklist to CLB: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 18.90
    • Market cap: $875M
    • EPS: 0.423
  2. Step 2 — Valuation checks

    • P/E: 44.68
    • FCF yield: 25.4%
    • Date checked: Dec 2, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.